Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
An American owned company Disclaimer All products sold on this website under the "BACKUP" brand are non-therapeutic in nature and intended for laboratory research purposes only
Visible body composition changes from the combination usually become apparent at weeks 6-8, when AOD 9604 has been active for 2-4 weeks alongside escalating tirzepatide doses
Vincent Nacouzi as your provider, he will administer a small dose of B12 intramuscularly, typically in your arm or thigh
Clinical studies specifically monitoring glucose metabolism through oral glucose tolerance tests found no significant changes in glucose handling, and fasting insulin levels remained stable throughout treatment periods lasting up to 24 weeks
Each mL of Dexamethasone Sodium Phosphate Injection 10 mg/mL contains dexamethasone sodium phosphate, equivalent to 10 mg dexamethasone phosphate or 8.33 mg dexamethasone
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
US$ 24.37
US$ 25.57
US$ 24.24
US$ 28.18
US$ 20.65
US$ 27.17
